$1.44
-0.09-5.88%
Last update: Nov 13, 8:56 AM
Universe Pharmaceuticals Inc
UPCNASDAQ
Universe Pharmaceuticals fell 59.4% from $3.77 to $1.53, behind the S&P 500's +12.7%. Its worst day was Jun 30 (−49.9%), and its low came Nov 6 at $1.39.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-8.06 was reported on $17.9M revenue.
+6.3% · S&P 500 −0.3%
Universe Pharmaceuticals closed at its highest level of the year, 223.1% above where the year started.
Story events cover the past 12 months · Times ET
+311.5%, the year's best day, on 55M shares, the year's heaviest volume · S&P 500 +1.6%
Universe Pharmaceuticals shares rose 105.1%, while the S&P 500 rose 1.4%.
+105.1% · S&P 500 +1.4%
Universe Pharmaceuticals closed at its lowest level of the year, 63.1% below where the year started.
−0.7% · S&P 500 +0.3%
Where it ended: a close of $1.53 on Nov 12, 2026. Up next: FY 2026 earnings on Jan 28, 2027.
Nothing in the past 12 months.
All UPC analyst actionsNothing in the past 12 months.
All UPC dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for UPC and SPY from Benzinga historical bars. Not investment advice.
